Sanjar Pharma Llp Profile
Key Indicators
- Obligation of Contribution ₹ 4.00 Cr
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.52 Cr
- Satisfied Charges ₹ 11.00 Cr
- Revenue Growth 18.57%
- Profit Growth 261.67%
- Ebitda 103.89%
- Total Assets -22.17%
About Sanjar Pharma Llp
Sanjar Pharma Llp (SPL) is 10 Year, 11 Months old Limited Liability Partnership 04 March 2014. Its registered office is in Sabarkantha, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 4.00 Cr as per MCA.
Company Details
-
Location
Sabarkantha, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAC-1431
-
Incorporation Date
04 Mar 2014
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Ahmedabad
-
Company Classification
Limited Liability Partnership
Industry
What products or services does Sanjar Pharma Llp offer?
Sanjar Pharma Llp offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines, Anti Allergic Drug, Pain Relief Drugs & Pharmaceuticals, Anesthetic, Anti Infective Agent, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Sanjar Pharma Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohmadazaz Mukdiwala
|
Designated Partner | 04-Mar-2014 | Current |
|
Mohmadmoin Modasiya
|
Designated Partner | 04-Mar-2014 | Current |
Financial Performance of Sanjar Pharma Llp.
Sanjar Pharma Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 18.57% increase. The company also saw a substantial improvement in profitability, with a 261.67% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjar Pharma Llp?
Unlock access to Sanjar Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.52 Cr
₹11.00 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 4.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2018 | Axis Bank Limited | ₹4.52 Cr | Open |
| 24 Nov 2015 | Dena Bank | ₹11.00 Cr | Satisfied |
How Many Employees Work at Sanjar Pharma Llp?
Sanjar Pharma Llp has a workforce of 15 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjar Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjar Pharma Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.